Interleukin-10 (IL-10) inhibits borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated lyme arthritis

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4421-4430

  Hansen, Emily S ^a   Medić, Velinka ^a   Kuo, Joseph ^b,c   Warner, Thomas F ^c   Schell, Ronald F ^b,c   Nardelli, Dean T ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; BONE; BORRELIA BURGDORFERI; BORRELIA INFECTION; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; LYME DISEASE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; SPIROCHETE; SPLEEN CELL;

ANIMALS; ANTIBODIES; ARTHRITIS; BORRELIA BURGDORFERI; CELLS, CULTURED; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-17; LYME DISEASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TH17 CELLS;

EID: 84890146071     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01129-13     Document Type: Article

References (52)

1. Steere AC, Coburn J, Glickstein L. 2004. The emergence of Lyme disease. J. Clin. Invest. 113:1093-1101.
2. Giambartolomei GH, Dennis VA, Philipp MT. 1998. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect. Immun. 66:2691-2697.
3. Brown JP, Zachary JF, Teuscher C, Weis JJ, Wooten RM. 1999. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67:5142-5150.
4. Ganapamo F, Dennis VA, Philipp MT. 2003. Differential acquired immune responsiveness to bacterial lipoproteins in Lyme disease-resistant and -susceptible mouse strains. Eur. J. Immunol. 33:1934-1940.
5. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. 1991. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174:593-601.
6. Gross DM, Steere AC, Huber BT. 1998. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160:1022-1028.
7. Strle K, Shin JJ, Glickstein LJ, Steere AC. 2012. Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum. 64:1497-1507.
8. Shen S, Shin JJ, Strle K, McHugh G, Li X, Glickstein LJ, Drouin EE, Steere AC. 2010. Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis. Arthritis Rheum. 62:2127-2137.
9. Brown CR, Reiner SL. 1999. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67:3329-3333.
10. Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, DeCoster DJ, Callister SM, Schell RF. 2003. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin. Diagn. Lab. Immunol. 10:44-52.
11. Munson EL, DeCoster DJ, Nardelli DT, England DM, Callister SM, Schell RF. 2004. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice. Clin. Diagn. Lab. Immunol. 11:35-41.
12. Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. 2003. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71:3437-3442.
13. Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM, Schell RF. 2004. Association of CD4+CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin. Diagn. Lab. Immunol. 11:1075-1084.
14. Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. 2006. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin. Vaccine Immunol. 13:289-296.
15. Nardelli DT, Luk KHK, Kotloski NJ, Warner TF, Torrealba JR, Callister SM, Schell RF. 2008. Role of IL-17, transforming growth factor-ß, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and challenged mice. FEMS Immunol. Med. Microbiol. 53:265-274.
16. Nardelli DT, Luedtke JO, Munson EL, Warner TF, Callister SM, Schell RF. 2010. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. FEMS Immunol. Med. Microbiol. 60:78-89.
17. Kotloski NJ, Nardelli DT, Peterson SH, Torrealba JR, Warner TF, Callister SM, Schell RF. 2008. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin. Vaccine Immunol. 15:1199-1207.
18. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107-6115.
19. Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, Benagiano M, Paccani SR, Sambri V, Del Prete G, Baldari CT, Zanotti G, Montecucco C, D'Elios MM, de Bernard M. 2008. Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum. 58:3609-3617.
20. Codolo G, Bossi F, Durigutto P, Bella CD, Fischetti F, Amedei A, Tedesco F, D'Elios S, Cimmino M, Micheletti A, Cassatella MA, D'Elios MM, de Bernard M. 2013. Orchestration of inflammatory and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil activating protein A. Arthritis Rheum. 65:1232-1242.
21. Huber S, Gagliani N, Esplugues E, O'Connor W, Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA. 2011. Th17 cells express interluekin-10 receptor and are controlled by Foxp3-and Foxp3+regulatory CD4+T cells in an interleukin-10 dependent manner. Immunity 34:554-565.
22. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
23. Nardelli DT, Callister SM, Schell RF. 2008. Lyme arthritis: current concepts and a change in paradigm. Clin. Vaccine Immunol. 15:21-34.
24. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. 2000. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12:1092-1099.
25. Agarwal S, Misra R, Aggarwal A. 2008. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J. Rheumatol. 35:515-519.
26. Pinto LG, Cunha TM, Vieira SM, Lemos HP, Verri WA, Jr, Cunha FQ, Ferreira SH. 2010. IL-17 mediates articular hypernociception in antigeninduced arthritis in mice. Pain 148:247-256.
27. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LAB, van den Berg WB. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50:650-659.
28. Ganapamo F, Dennis VA, Philipp MT. 2000. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect. Immun. 68:7162-7165.
29. Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, Kamradt T, Sieper J. 1997. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 40:69-79.
30. Sonderegger FL, Ma Y, Maylor-Hagan H, Brewster J, Huang X, Spangrude GJ, Zachary JF, Weis JH, Weis JJ. 2012. Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis. J. Immunol. 188:1381-1393.
31. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177:5377-5385.
32. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A, Sallusto F. 2012. Pathogeninduced human Th17 cells produce IFN-γ or IL-10 and are regulated by IL-1ß. Nature 484:514-518.
33. Pappu R, Ramirez-Carrozzi V, Sambandam A. 2011. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 134:8-16.
34. Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J. 2011. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J. Infect. Dis. 204:253-262.
35. Gonzalez-Lombana C, Gimblet C, Bacellar O, Oliveira WW, Passos S, Carvalho LP, Goldschmidt M, Carvalho EM, Scott P. 2013. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog. 9:e1003243. doi:10.1371/journal.ppat.1003243.
36. Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau CS, Cao X, Lu L. 2012. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am. J. Pathol. 180:2375-2385.
37. Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, Park SH, Kim HY, Min JK. 2010. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+T cell population of rheumatoid arthritis patients. Immunol. Lett. 127:150-156.
38. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8:1390-1397.
39. Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, McClanahan T, Hämmerling G, Li MO, Cua DJ, McGeachy MJ. 2011. Foxp3+ regulatory T cells promote T helper 17 cell development in vivo through regulation of inteleukin-2. Immunity 34:409-421.
40. Oosting M, ter Hofstede H, van de Veerdonk FL, Sturm P, Kullberg BJ, van der Meer JWM, Netea MG, Joosten LAB. 2011. Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease. Infect. Immun. 79:4681-4687.
41. Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. 2011. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin. Vaccine Immunol. 18:1125-1132.
42. Nardelli DT, Cloute JP, Luk KHK, Torrealba J, Warner TF, Callister SM, Schell RF. 2005. CD4+CD25+ T cells prevent arthritis associated with Borrelia vaccination and infection. Clin. Diagn. Lab. Immunol. 12:786-792.
43. Nardelli DT, Warner TF, Callister SM, Schell RF. 2006. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production. Clin. Vaccine Immunol. 13:884-891.
44. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
45. Vudattu NK, Strle K, Steere AC, Drouin EE. 2013. Dysregulation of CD4+CD25high T cells in the synovial fluid of patients with antibioticrefractory Lyme arthritis. Arthritis Rheum. 65:1643-1653.
46. Lazarus JJ, Kay MA, McCarter AL, Wooten RM. 2008. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect. Immun. 76:1153-1162.
47. Murthy PK, Dennis VA, Lasater BL, Philipp MT. 2000. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 68:6663-6669.
48. Diterich I, Härter L, Hassler D, Wendel A, Hartung T. 2001. Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect. Immun. 69:687-694.
49. Crandall H, Dunn DM, Ma Y, Wooten RM, Zachary JF, Weis JH, Weiss RB, Weis JJ. 2006. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J. Immunol. 177:7930-7942.
50. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM. 2006. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J. Immunol. 177:7076-7085.
51. Gautam A, Dixit S, Philipp MT, Singh SR, Morici LA, Kaushal D, Dennis VA. 2011. Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect. Immun. 79:4876-4892.
52. Shibui A, Shimura E, Nambu A, Yamaguchi S, Leonard WJ, Okumura K, Sugano S, Sudo K, Nakae S. 2012. Th17 cell-derived IL-17 is dispensable for B cell antibody production. Cytokine 59:108-114.